Interphex Wraps Up in New York and Prepares for Global Rollout
Interphex2007, New York, NY (Apr. 27)-The Interphex2007 Conference and Exhibition concluded here on Thursday. As the three-day event reached its conclusion, however, Interphex will continue its global push, with several shows scheduled abroad this year.
Interphex2007, New York, NY (Apr. 26)-The Interphex2007 Conference and Exhibition concluded here on Thursday. As the three-day event reached its conclusion, however, Interphex will continue its global push, with several shows scheduled abroad this year.
Reflecting the growing importance of India and China in the pharmaceutical supply chain, Interphex is scheduled to be held this year in both countries: May 15–17 in Nanjing, China and Sept. 13–15 in Mumbai, India
Interphex also is scheduled for June 20–22 in Tokyo and in the fall in Mexico City, Mexico.
In addition to the New York installment of Interphex, the conference and exhibition was held in Puerto Rico in early February.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
